Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$319M |
| 2 |
GSK
GSK
|
+$230M |
| 3 |
LO
LORILLARD INC COM STK
LO
|
+$192M |
| 4 |
Verizon
VZ
|
+$174M |
| 5 |
Mastercard
MA
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.08B |
| 2 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$850M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$781M |
| 4 |
Bausch Health
BHC
|
+$466M |
| 5 |
Meta Platforms (Facebook)
META
|
+$407M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 7.58% |
| 2 | Technology | 5.48% |
| 3 | Financials | 4.9% |
| 4 | Energy | 3.61% |
| 5 | Consumer Discretionary | 3.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNV
3676
CALL
DELISTED
Synovus
SNV
| $410K | ﹤0.01% |
14,652
-3,880
| -21% | -$105K |
|
|
PGNX
3677
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $410K | ﹤0.01% |
81,981
+61,632
| +303% | +$388K |
|
3678
PUT
Globalstar
GSAT
$10.8B
| $409K | ﹤0.01% |
+9,080
| New | +$375K |
|
|
DNY
3679
CALL
DELISTED
DONNELLEY R R & SONS CO
DNY
| $409K | ﹤0.01% |
21,500
-59,500
| -73% | -$1.13M |
|
3680
CALL
Nabors Industries
NBR
$1.3B
| $408K | ﹤0.01% |
628
-3,402
| -84% | -$2.07M |
|
|
CRAY
3681
DELISTED
Cray, Inc.
CRAY
| $407K | ﹤0.01% |
14,521
+11,304
| +351% | +$359K |
|
|
TPC
3682
Tutor Perini Cor
TPC
$5.11B
| $406K | ﹤0.01% |
17,658
-8,638
| -33% | -$203K |
|
|
AMPE
3683
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $406K | ﹤0.01% |
193
+185
| +2,313% | +$315K |
|
3684
CALL
Oxford Industries
OXM
$534M
| $405K | ﹤0.01% |
5,400
+5,100
| +1,700% | +$287K |
|
|
DCH
3685
Dauch Corp
DCH
$1.6B
| $404K | ﹤0.01% |
16,131
-104,257
| -87% | -$2.56M |
|
3686
CALL
J.M. Smucker
SJM
$12.6B
| $403K | ﹤0.01% |
3,500
-1,800
| -34% | -$197K |
|
|
TTPH
3687
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $403K | ﹤0.01% |
559
-341
| -38% | -$256K |
|
|
BEAV
3688
CALL
DELISTED
B/E Aerospace Inc
BEAV
| $403K | ﹤0.01% |
6,400
-46,100
| -88% | -$2.83M |
|
|
CYBX
3689
CALL
DELISTED
CYBERONICS INC
CYBX
| $403K | ﹤0.01% |
6,300
+6,100
| +3,050% | +$371K |
|
|
VNR
3690
CALL
DELISTED
Vanguard Natural Resources, LLC
VNR
| $403K | ﹤0.01% |
+31,000
| New | +$482K |
|
|
STMP
3691
DELISTED
Stamps.com, Inc.
STMP
| $401K | ﹤0.01% |
5,969
-889
| -13% | -$47.3K |
|
3692
Saic
SAIC
$5.25B
| $400K | ﹤0.01% |
7,866
-1,093
| -12% | -$57.2K |
|
3693
PUT
NCR Voyix
VYX
$1.1B
| $400K | ﹤0.01% |
22,494
-8,150
| -27% | -$142K |
|
3694
Forestar Group
FOR
$1.47B
| $399K | ﹤0.01% |
26,471
+3,992
| +18% | +$58.8K |
|
3695
CALL
Wabtec
WAB
$50.1B
| $399K | ﹤0.01% |
4,200
-500
| -11% | -$45.1K |
|
|
IMMU
3696
DELISTED
Immunomedics Inc
IMMU
| $399K | ﹤0.01% |
133,005
+22,903
| +21% | +$99.6K |
|
|
CALD
3697
DELISTED
Callidus Software, Inc.
CALD
| $399K | ﹤0.01% |
33,151
+19,593
| +145% | +$285K |
|
|
LGF
3698
PUT
DELISTED
Lions Gate Entertainment
LGF
| $399K | ﹤0.01% |
12,100
-39,400
| -77% | -$1.24M |
|
|
IGTE
3699
PUT
DELISTED
IGATE CORPORATION
IGTE
| $399K | ﹤0.01% |
9,500
+9,100
| +2,275% | +$365K |
|
3700
ProShares Ultra Silver
AGQ
$1.48B
| $398K | ﹤0.01% |
9,709
-11,441
| -54% | -$488K |
|
Similar funds
Barclays's Q1 2015 Portfolio in Review
As of Q1 2015, Barclays held 7,637 positions worth $86.7B, down 17% from $104B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays withdrew a net $19.4B in Q1 2015, closing 488 positions and reducing 4,377 holdings. Its most notable exit was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019, an estimated $781M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 5.7% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in iPath Pure Beta Broad Commodity ETN worth $55.8M.
- Barclays's largest Q1 2015 buy was iPath Pure Beta Broad Commodity ETN: 1,861,500 shares worth $55.8M.
- Barclays added most to Envision Healthcare Holdings Inc in Q1 2015, an estimated $319M increase.
- Barclays's biggest Q1 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.08B.
- Barclays fully exited iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019 in Q1 2015, selling an estimated $781M.
- Barclays's ten largest holdings make up 25% of its $86.7B portfolio in Q1 2015.
- Barclays opened 330 new positions and closed 488 in Q1 2015.
- Barclays's portfolio value fell 17% quarter-over-quarter to $86.7B.
Based on Barclays's 13F filing for Q1 2015, filed 14 May 2015.